IP Library Granted Patent US 10,168,323
Granted Patent B2
US 10,168,323 · App. 14/204,868 · Granted Jan 1, 2019

Compositions and methods for capture of cellular targets of bioactive agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,168,323
App. No.
14/204,868
Granted
Jan 1, 2019
Kind
B2
Abstract

The present invention provides compositions and methods for capture and identification of the cellular targets of a bioactive agent. In particular, provided herein are bioactive agents tethered to capture ligand, cellular targets (optionally tagged with a reporter), capture proteins (optionally present as capture dimers), surfaces (e.g., displaying, capture ligands, capture proteins, or capture dimers), and methods of capturing and identifying the cellular targets of a bioactive agent therewith.

Claims (8)

1. A kit comprising:

(a) a cell that expresses a fusion of a bioluminescent reporter and a cellular target of a small molecule bioactive agent, wherein the cellular target is located within a cell;

(b) the small molecule bioactive agent tethered by a carbamate linker to a chloroalkane capture ligand, wherein the small molecule bioactive agent tethered to a chloroalkane capture ligand is cell permeable, and wherein the small molecule bioactive agent is capable of non-covalently binding to the cellular target upon interaction thereof under intracellular conditions; and

(c) a solid surface displaying a capture protein, wherein the capture protein comprises a modified dehalogenase configured to covalently bind to the chloroalkane capture ligand upon interaction thereof.

2. The kit of claim 1 , wherein the bioluminescent reporter comprises a polypeptide with at least 70% sequence identity with SEQ ID NO.: 3.

3. The kit of claim 1 , wherein the capture protein comprises at least 70% sequence identity with SEQ ID NO.: 1.

4. The kit of claim 1 , wherein the solid surface is selected from the list consisting of: a well, a tube, a slide, a plate, a matrix, resin or a bead.

5. The kit of claim 4 , wherein the solid surface is magnetic or paramagnetic.

Assignments (3)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2016
From: ZHU, JI
To: PROMEGA CORPORATION
Reel/Frame 040215/0304 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2014
From: HURST, ROBIN; NATH, NIDHI; OHANA, RACHEL FRIEDMAN; OTTO, PAUL; URH, MARJETA; WOOD, KEITH; UYEDA, HARRY TETSUO; KIRKLAND, THOMAS; HITKO, CAROLYN W.; KLAUBERT, DIETER; MEISENHEIMER, PONCHO
To: PROMEGA CORPORATION
Reel/Frame 033411/0380 →